Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
Conditions: Schizophrenia; Treatment-resistant Schizophrenia; Side Effect; Lipid Metabolism Disorders; Diabetes; NAFLD; Psychosis Interventions: Drug: Aripiprazole; Drug: Paliperidone Sponsors: Consorcio Centro de Investigaci ón Biomédica en Red (CIBER); Instituto de Salud Carlos III Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abilify | Biology | Diabetes | Endocrinology | Invega | Non-alcoholic Fatty Liver Diseases (NAFLD) | Research | Schizophrenia